// insider-profile

HAUSMAN DIANA

DirectorTitleChief Medical OfficerView on SEC.gov ↗

This page tracks every SEC Form 4 filing by HAUSMAN DIANA, Chief Medical Officer: 10 transactions in total, including 2 open-market purchases and 1 sale. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by HAUSMAN DIANA.

// track-record

$20K
Total purchased
$42K
Total sold
3
2B · 1S transactions
Net seller
Overall direction

Most active in

Largest trade: $11K in IMRX (Jul 2025)Filing history: May 2023Jun 2026Based on last 10 filings

Transaction History

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026HAUSMAN DIANAIMRX
Award
33,350$0.00$0K
Jul 2, 2025HAUSMAN DIANAIMRX
Purchase
3,000$3.62$11K
Jul 2, 2025HAUSMAN DIANAIMRX
Purchase
2,500$3.60$9K
Jun 13, 2025HAUSMAN DIANAIMRX
Award
33,350$0.00$0K
Jun 12, 2024HAUSMAN DIANAIMRX
Award
33,350$0.00$0K

5 more transactions hidden

Free account · No credit card required

Building something? Get API access →

// how to read this

Reading an insider's Form 4 history

Corporate insiders — directors, officers, and holders of more than 10% of a company's stock — must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.

The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.